nodes	percent_of_prediction	percent_of_DWPC	metapath
Ursodeoxycholic acid—ABCB11—Vincristine—colon cancer	0.147	0.231	CbGbCtD
Ursodeoxycholic acid—ABCC4—Fluorouracil—colon cancer	0.143	0.224	CbGbCtD
Ursodeoxycholic acid—ABCC2—Irinotecan—colon cancer	0.0886	0.139	CbGbCtD
Ursodeoxycholic acid—ABCC4—Methotrexate—colon cancer	0.0788	0.123	CbGbCtD
Ursodeoxycholic acid—ABCC2—Vincristine—colon cancer	0.0774	0.121	CbGbCtD
Ursodeoxycholic acid—SLCO1A2—Methotrexate—colon cancer	0.0566	0.0886	CbGbCtD
Ursodeoxycholic acid—ABCC2—Methotrexate—colon cancer	0.0469	0.0734	CbGbCtD
Ursodeoxycholic acid—SLC10A2—bile—colon cancer	0.0309	0.204	CbGeAlD
Ursodeoxycholic acid—NR1H4—bile—colon cancer	0.0243	0.161	CbGeAlD
Ursodeoxycholic acid—SLC10A1—bile—colon cancer	0.0167	0.11	CbGeAlD
Ursodeoxycholic acid—ABCB11—bile—colon cancer	0.0165	0.109	CbGeAlD
Ursodeoxycholic acid—ABCC2—bile—colon cancer	0.0084	0.0555	CbGeAlD
Ursodeoxycholic acid—NR1H4—gall bladder—colon cancer	0.00674	0.0446	CbGeAlD
Ursodeoxycholic acid—SLC10A2—renal system—colon cancer	0.00411	0.0272	CbGeAlD
Ursodeoxycholic acid—AKR1C2—liver—colon cancer	0.00376	0.0249	CbGeAlD
Ursodeoxycholic acid—AKR1C2—Metapathway biotransformation—CHST4—colon cancer	0.00374	0.116	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—digestive system—colon cancer	0.00337	0.0223	CbGeAlD
Ursodeoxycholic acid—NR1H4—renal system—colon cancer	0.00324	0.0214	CbGeAlD
Ursodeoxycholic acid—SLC10A2—vagina—colon cancer	0.00298	0.0197	CbGeAlD
Ursodeoxycholic acid—AKR1C2—lymph node—colon cancer	0.00289	0.0191	CbGeAlD
Ursodeoxycholic acid—NR1H4—digestive system—colon cancer	0.00265	0.0175	CbGeAlD
Ursodeoxycholic acid—SLC10A1—renal system—colon cancer	0.00223	0.0147	CbGeAlD
Ursodeoxycholic acid—NR1H4—liver—colon cancer	0.00198	0.0131	CbGeAlD
Ursodeoxycholic acid—SLC10A1—digestive system—colon cancer	0.00183	0.0121	CbGeAlD
Ursodeoxycholic acid—ABCB11—digestive system—colon cancer	0.0018	0.0119	CbGeAlD
Ursodeoxycholic acid—AKR1C2—Metapathway biotransformation—CHST5—colon cancer	0.00172	0.0533	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.00168	0.0523	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.00153	0.0474	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—lymph node—colon cancer	0.00152	0.01	CbGeAlD
Ursodeoxycholic acid—ABCC2—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00138	0.0428	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—liver—colon cancer	0.00136	0.00899	CbGeAlD
Ursodeoxycholic acid—ABCB11—liver—colon cancer	0.00134	0.00889	CbGeAlD
Ursodeoxycholic acid—SLCO1A2—renal system—colon cancer	0.0012	0.00794	CbGeAlD
Ursodeoxycholic acid—ABCC4—renal system—colon cancer	0.00116	0.00764	CbGeAlD
Ursodeoxycholic acid—ABCC2—renal system—colon cancer	0.00112	0.00739	CbGeAlD
Ursodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00102	0.0315	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000992	0.0308	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—digestive system—colon cancer	0.000985	0.00651	CbGeAlD
Ursodeoxycholic acid—ABCC4—digestive system—colon cancer	0.000948	0.00627	CbGeAlD
Ursodeoxycholic acid—ABCC2—digestive system—colon cancer	0.000917	0.00606	CbGeAlD
Ursodeoxycholic acid—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000894	0.0278	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000876	0.0272	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—bone marrow—colon cancer	0.000874	0.00578	CbGeAlD
Ursodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.000756	0.0235	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000754	0.0234	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—liver—colon cancer	0.000734	0.00485	CbGeAlD
Ursodeoxycholic acid—CYP2E1—renal system—colon cancer	0.000706	0.00467	CbGeAlD
Ursodeoxycholic acid—ABCC4—liver—colon cancer	0.000706	0.00467	CbGeAlD
Ursodeoxycholic acid—ABCC2—liver—colon cancer	0.000683	0.00452	CbGeAlD
Ursodeoxycholic acid—ABCC2—Irinotecan Pathway—APC—colon cancer	0.000635	0.0197	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00061	0.0189	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metapathway biotransformation—CHST4—colon cancer	0.000601	0.0187	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—lymphoid tissue—colon cancer	0.000586	0.00388	CbGeAlD
Ursodeoxycholic acid—CYP2E1—digestive system—colon cancer	0.000579	0.00383	CbGeAlD
Ursodeoxycholic acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00057	0.0177	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—lymph node—colon cancer	0.000541	0.00358	CbGeAlD
Ursodeoxycholic acid—ABCC2—lymph node—colon cancer	0.000524	0.00346	CbGeAlD
Ursodeoxycholic acid—ABCC4—Fluoropyrimidine Activity—TYMS—colon cancer	0.000517	0.016	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—CA7—colon cancer	0.000492	0.0153	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000491	0.0152	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000455	0.0141	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000441	0.0137	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—CA7—colon cancer	0.000438	0.0136	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000433	0.0135	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—liver—colon cancer	0.000431	0.00285	CbGeAlD
Ursodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00043	0.0133	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000414	0.0129	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000396	0.0123	CbGpPWpGaD
Ursodeoxycholic acid—Jaundice—Capecitabine—colon cancer	0.000318	0.00178	CcSEcCtD
Ursodeoxycholic acid—Infection—Vincristine—colon cancer	0.000317	0.00178	CcSEcCtD
Ursodeoxycholic acid—Urinary tract infection—Capecitabine—colon cancer	0.000317	0.00178	CcSEcCtD
Ursodeoxycholic acid—Conjunctivitis—Capecitabine—colon cancer	0.000317	0.00178	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Fluorouracil—colon cancer	0.000316	0.00177	CcSEcCtD
Ursodeoxycholic acid—Confusional state—Irinotecan—colon cancer	0.000313	0.00176	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Vincristine—colon cancer	0.000313	0.00176	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Vincristine—colon cancer	0.000312	0.00175	CcSEcCtD
Ursodeoxycholic acid—Haematuria—Capecitabine—colon cancer	0.000311	0.00175	CcSEcCtD
Ursodeoxycholic acid—Oedema—Irinotecan—colon cancer	0.00031	0.00174	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Fluorouracil—colon cancer	0.00031	0.00174	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Fluorouracil—colon cancer	0.00031	0.00174	CcSEcCtD
Ursodeoxycholic acid—Infection—Irinotecan—colon cancer	0.000308	0.00173	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Vincristine—colon cancer	0.000308	0.00173	CcSEcCtD
Ursodeoxycholic acid—Hepatobiliary disease—Capecitabine—colon cancer	0.000308	0.00173	CcSEcCtD
Ursodeoxycholic acid—Epistaxis—Capecitabine—colon cancer	0.000307	0.00173	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Fluorouracil—colon cancer	0.000306	0.00172	CcSEcCtD
Ursodeoxycholic acid—Shock—Irinotecan—colon cancer	0.000305	0.00172	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Irinotecan—colon cancer	0.000304	0.00171	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Irinotecan—colon cancer	0.000304	0.00171	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Vincristine—colon cancer	0.000304	0.00171	CcSEcCtD
Ursodeoxycholic acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000301	0.00936	CbGpPWpGaD
Ursodeoxycholic acid—Hyperhidrosis—Irinotecan—colon cancer	0.0003	0.00169	CcSEcCtD
Ursodeoxycholic acid—Confusional state—Fluorouracil—colon cancer	0.0003	0.00168	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Vincristine—colon cancer	0.000298	0.00167	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—ODC1—colon cancer	0.000298	0.00925	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—CHST5—colon cancer	0.000298	0.00925	CbGpPWpGaD
Ursodeoxycholic acid—Oedema—Fluorouracil—colon cancer	0.000297	0.00167	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Irinotecan—colon cancer	0.000296	0.00166	CcSEcCtD
Ursodeoxycholic acid—Infection—Fluorouracil—colon cancer	0.000295	0.00166	CcSEcCtD
Ursodeoxycholic acid—Haemoglobin—Capecitabine—colon cancer	0.000294	0.00165	CcSEcCtD
Ursodeoxycholic acid—Rhinitis—Capecitabine—colon cancer	0.000293	0.00165	CcSEcCtD
Ursodeoxycholic acid—Haemorrhage—Capecitabine—colon cancer	0.000292	0.00164	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Fluorouracil—colon cancer	0.000292	0.00164	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Fluorouracil—colon cancer	0.000291	0.00164	CcSEcCtD
Ursodeoxycholic acid—Liver function test abnormal—Methotrexate—colon cancer	0.000291	0.00163	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Vincristine—colon cancer	0.00029	0.00163	CcSEcCtD
Ursodeoxycholic acid—Pharyngitis—Capecitabine—colon cancer	0.00029	0.00163	CcSEcCtD
Ursodeoxycholic acid—Tachycardia—Fluorouracil—colon cancer	0.00029	0.00163	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Irinotecan—colon cancer	0.00029	0.00163	CcSEcCtD
Ursodeoxycholic acid—Urinary tract disorder—Capecitabine—colon cancer	0.000289	0.00162	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Vincristine—colon cancer	0.000288	0.00162	CcSEcCtD
Ursodeoxycholic acid—Oedema peripheral—Capecitabine—colon cancer	0.000288	0.00162	CcSEcCtD
Ursodeoxycholic acid—Connective tissue disorder—Capecitabine—colon cancer	0.000287	0.00161	CcSEcCtD
Ursodeoxycholic acid—Urethral disorder—Capecitabine—colon cancer	0.000287	0.00161	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Vincristine—colon cancer	0.000286	0.00161	CcSEcCtD
Ursodeoxycholic acid—Breast disorder—Methotrexate—colon cancer	0.000284	0.0016	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Fluorouracil—colon cancer	0.000283	0.00159	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—CA7—colon cancer	0.000282	0.00877	CbGpPWpGaD
Ursodeoxycholic acid—Visual impairment—Capecitabine—colon cancer	0.000282	0.00158	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Irinotecan—colon cancer	0.000281	0.00158	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Irinotecan—colon cancer	0.000279	0.00157	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Fluorouracil—colon cancer	0.000278	0.00156	CcSEcCtD
Ursodeoxycholic acid—Decreased appetite—Vincristine—colon cancer	0.000277	0.00156	CcSEcCtD
Ursodeoxycholic acid—Dyspnoea—Irinotecan—colon cancer	0.000277	0.00156	CcSEcCtD
Ursodeoxycholic acid—Somnolence—Irinotecan—colon cancer	0.000276	0.00155	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Metapathway biotransformation—CHST5—colon cancer	0.000276	0.00857	CbGpPWpGaD
Ursodeoxycholic acid—Gastrointestinal disorder—Vincristine—colon cancer	0.000275	0.00155	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Vincristine—colon cancer	0.000275	0.00154	CcSEcCtD
Ursodeoxycholic acid—Eye disorder—Capecitabine—colon cancer	0.000273	0.00154	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Irinotecan—colon cancer	0.000273	0.00154	CcSEcCtD
Ursodeoxycholic acid—Tinnitus—Capecitabine—colon cancer	0.000273	0.00153	CcSEcCtD
Ursodeoxycholic acid—Constipation—Vincristine—colon cancer	0.000273	0.00153	CcSEcCtD
Ursodeoxycholic acid—Pain—Vincristine—colon cancer	0.000273	0.00153	CcSEcCtD
Ursodeoxycholic acid—Asthma—Methotrexate—colon cancer	0.000272	0.00153	CcSEcCtD
Ursodeoxycholic acid—Cardiac disorder—Capecitabine—colon cancer	0.000271	0.00152	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000271	0.00152	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00027	0.0084	CbGpPWpGaD
Ursodeoxycholic acid—Decreased appetite—Irinotecan—colon cancer	0.00027	0.00152	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Fluorouracil—colon cancer	0.000269	0.00151	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Irinotecan—colon cancer	0.000268	0.00151	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Irinotecan—colon cancer	0.000268	0.0015	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Fluorouracil—colon cancer	0.000267	0.0015	CcSEcCtD
Ursodeoxycholic acid—Pancreatitis—Methotrexate—colon cancer	0.000267	0.0015	CcSEcCtD
Ursodeoxycholic acid—Constipation—Irinotecan—colon cancer	0.000266	0.00149	CcSEcCtD
Ursodeoxycholic acid—Pain—Irinotecan—colon cancer	0.000266	0.00149	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—CHST5—colon cancer	0.000265	0.00824	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—ODC1—colon cancer	0.000265	0.00824	CbGpPWpGaD
Ursodeoxycholic acid—Angiopathy—Capecitabine—colon cancer	0.000265	0.00149	CcSEcCtD
Ursodeoxycholic acid—Dyspnoea—Fluorouracil—colon cancer	0.000265	0.00149	CcSEcCtD
Ursodeoxycholic acid—Somnolence—Fluorouracil—colon cancer	0.000264	0.00149	CcSEcCtD
Ursodeoxycholic acid—Immune system disorder—Capecitabine—colon cancer	0.000264	0.00148	CcSEcCtD
Ursodeoxycholic acid—Mediastinal disorder—Capecitabine—colon cancer	0.000264	0.00148	CcSEcCtD
Ursodeoxycholic acid—Chills—Capecitabine—colon cancer	0.000262	0.00147	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Fluorouracil—colon cancer	0.000262	0.00147	CcSEcCtD
Ursodeoxycholic acid—Arrhythmia—Capecitabine—colon cancer	0.000261	0.00147	CcSEcCtD
Ursodeoxycholic acid—Abdominal discomfort—Methotrexate—colon cancer	0.000261	0.00147	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Vincristine—colon cancer	0.000261	0.00146	CcSEcCtD
Ursodeoxycholic acid—Decreased appetite—Fluorouracil—colon cancer	0.000259	0.00145	CcSEcCtD
Ursodeoxycholic acid—Alopecia—Capecitabine—colon cancer	0.000258	0.00145	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000257	0.00144	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—CA7—colon cancer	0.000256	0.00795	CbGpPWpGaD
Ursodeoxycholic acid—Feeling abnormal—Irinotecan—colon cancer	0.000256	0.00144	CcSEcCtD
Ursodeoxycholic acid—Malnutrition—Capecitabine—colon cancer	0.000255	0.00143	CcSEcCtD
Ursodeoxycholic acid—Dysuria—Methotrexate—colon cancer	0.000254	0.00143	CcSEcCtD
Ursodeoxycholic acid—Pain—Fluorouracil—colon cancer	0.000254	0.00143	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Irinotecan—colon cancer	0.000254	0.00143	CcSEcCtD
Ursodeoxycholic acid—Upper respiratory tract infection—Methotrexate—colon cancer	0.000253	0.00142	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Vincristine—colon cancer	0.000252	0.00142	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Vincristine—colon cancer	0.000252	0.00142	CcSEcCtD
Ursodeoxycholic acid—Flatulence—Capecitabine—colon cancer	0.000251	0.00141	CcSEcCtD
Ursodeoxycholic acid—Photosensitivity reaction—Methotrexate—colon cancer	0.000248	0.00139	CcSEcCtD
Ursodeoxycholic acid—Back pain—Capecitabine—colon cancer	0.000246	0.00138	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Irinotecan—colon cancer	0.000245	0.00138	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Irinotecan—colon cancer	0.000245	0.00138	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Fluorouracil—colon cancer	0.000245	0.00138	CcSEcCtD
Ursodeoxycholic acid—Muscle spasms—Capecitabine—colon cancer	0.000245	0.00138	CcSEcCtD
Ursodeoxycholic acid—Pneumonia—Methotrexate—colon cancer	0.000244	0.00137	CcSEcCtD
Ursodeoxycholic acid—Infestation—Methotrexate—colon cancer	0.000243	0.00136	CcSEcCtD
Ursodeoxycholic acid—Infestation NOS—Methotrexate—colon cancer	0.000243	0.00136	CcSEcCtD
Ursodeoxycholic acid—Depression—Methotrexate—colon cancer	0.000242	0.00136	CcSEcCtD
Ursodeoxycholic acid—Renal failure—Methotrexate—colon cancer	0.000238	0.00134	CcSEcCtD
Ursodeoxycholic acid—NR1H4—PPARA activates gene expression—PPARG—colon cancer	0.000238	0.0074	CbGpPWpGaD
Ursodeoxycholic acid—Ill-defined disorder—Capecitabine—colon cancer	0.000236	0.00133	CcSEcCtD
Ursodeoxycholic acid—Urticaria—Fluorouracil—colon cancer	0.000236	0.00133	CcSEcCtD
Ursodeoxycholic acid—Conjunctivitis—Methotrexate—colon cancer	0.000236	0.00132	CcSEcCtD
Ursodeoxycholic acid—Anaemia—Capecitabine—colon cancer	0.000235	0.00132	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Fluorouracil—colon cancer	0.000235	0.00132	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Vincristine—colon cancer	0.000235	0.00132	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.000233	0.00725	CbGpPWpGaD
Ursodeoxycholic acid—Sweating—Methotrexate—colon cancer	0.000233	0.00131	CcSEcCtD
Ursodeoxycholic acid—Haematuria—Methotrexate—colon cancer	0.000231	0.0013	CcSEcCtD
Ursodeoxycholic acid—Malaise—Capecitabine—colon cancer	0.00023	0.00129	CcSEcCtD
Ursodeoxycholic acid—Hepatobiliary disease—Methotrexate—colon cancer	0.000229	0.00129	CcSEcCtD
Ursodeoxycholic acid—Epistaxis—Methotrexate—colon cancer	0.000229	0.00129	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Capecitabine—colon cancer	0.000229	0.00129	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Irinotecan—colon cancer	0.000229	0.00129	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Vincristine—colon cancer	0.000229	0.00129	CcSEcCtD
Ursodeoxycholic acid—Syncope—Capecitabine—colon cancer	0.000228	0.00128	CcSEcCtD
Ursodeoxycholic acid—Leukopenia—Capecitabine—colon cancer	0.000228	0.00128	CcSEcCtD
Ursodeoxycholic acid—Palpitations—Capecitabine—colon cancer	0.000225	0.00126	CcSEcCtD
Ursodeoxycholic acid—Loss of consciousness—Capecitabine—colon cancer	0.000224	0.00126	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Irinotecan—colon cancer	0.000223	0.00125	CcSEcCtD
Ursodeoxycholic acid—Cough—Capecitabine—colon cancer	0.000222	0.00125	CcSEcCtD
Ursodeoxycholic acid—Hypertension—Capecitabine—colon cancer	0.00022	0.00123	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Fluorouracil—colon cancer	0.000219	0.00123	CcSEcCtD
Ursodeoxycholic acid—Haemoglobin—Methotrexate—colon cancer	0.000219	0.00123	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Vincristine—colon cancer	0.000218	0.00123	CcSEcCtD
Ursodeoxycholic acid—Haemorrhage—Methotrexate—colon cancer	0.000218	0.00122	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Capecitabine—colon cancer	0.000217	0.00122	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Capecitabine—colon cancer	0.000217	0.00122	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Capecitabine—colon cancer	0.000217	0.00122	CcSEcCtD
Ursodeoxycholic acid—Pharyngitis—Methotrexate—colon cancer	0.000216	0.00121	CcSEcCtD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000215	0.00121	CcSEcCtD
Ursodeoxycholic acid—Urinary tract disorder—Methotrexate—colon cancer	0.000215	0.00121	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Capecitabine—colon cancer	0.000214	0.0012	CcSEcCtD
Ursodeoxycholic acid—Urethral disorder—Methotrexate—colon cancer	0.000213	0.0012	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Irinotecan—colon cancer	0.000212	0.00119	CcSEcCtD
Ursodeoxycholic acid—Dry mouth—Capecitabine—colon cancer	0.000212	0.00119	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Vincristine—colon cancer	0.000211	0.00118	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Fluorouracil—colon cancer	0.00021	0.00118	CcSEcCtD
Ursodeoxycholic acid—Visual impairment—Methotrexate—colon cancer	0.00021	0.00118	CcSEcCtD
Ursodeoxycholic acid—Confusional state—Capecitabine—colon cancer	0.00021	0.00118	CcSEcCtD
Ursodeoxycholic acid—Oedema—Capecitabine—colon cancer	0.000208	0.00117	CcSEcCtD
Ursodeoxycholic acid—Infection—Capecitabine—colon cancer	0.000206	0.00116	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Irinotecan—colon cancer	0.000205	0.00115	CcSEcCtD
Ursodeoxycholic acid—Shock—Capecitabine—colon cancer	0.000204	0.00115	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Capecitabine—colon cancer	0.000204	0.00114	CcSEcCtD
Ursodeoxycholic acid—Eye disorder—Methotrexate—colon cancer	0.000203	0.00114	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Fluorouracil—colon cancer	0.000203	0.00114	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Capecitabine—colon cancer	0.000203	0.00114	CcSEcCtD
Ursodeoxycholic acid—Tinnitus—Methotrexate—colon cancer	0.000203	0.00114	CcSEcCtD
Ursodeoxycholic acid—Tachycardia—Capecitabine—colon cancer	0.000203	0.00114	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Vincristine—colon cancer	0.000203	0.00114	CcSEcCtD
Ursodeoxycholic acid—Cardiac disorder—Methotrexate—colon cancer	0.000202	0.00114	CcSEcCtD
Ursodeoxycholic acid—Skin disorder—Capecitabine—colon cancer	0.000202	0.00113	CcSEcCtD
Ursodeoxycholic acid—Rash—Vincristine—colon cancer	0.000201	0.00113	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Capecitabine—colon cancer	0.000201	0.00113	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Vincristine—colon cancer	0.000201	0.00113	CcSEcCtD
Ursodeoxycholic acid—Headache—Vincristine—colon cancer	0.0002	0.00112	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Capecitabine—colon cancer	0.000198	0.00111	CcSEcCtD
Ursodeoxycholic acid—Angiopathy—Methotrexate—colon cancer	0.000198	0.00111	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Irinotecan—colon cancer	0.000197	0.00111	CcSEcCtD
Ursodeoxycholic acid—Immune system disorder—Methotrexate—colon cancer	0.000197	0.0011	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Fluorouracil—colon cancer	0.000197	0.0011	CcSEcCtD
Ursodeoxycholic acid—Mediastinal disorder—Methotrexate—colon cancer	0.000196	0.0011	CcSEcCtD
Ursodeoxycholic acid—Rash—Irinotecan—colon cancer	0.000196	0.0011	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Irinotecan—colon cancer	0.000196	0.0011	CcSEcCtD
Ursodeoxycholic acid—Chills—Methotrexate—colon cancer	0.000195	0.0011	CcSEcCtD
Ursodeoxycholic acid—Headache—Irinotecan—colon cancer	0.000195	0.00109	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Capecitabine—colon cancer	0.000194	0.00109	CcSEcCtD
Ursodeoxycholic acid—Alopecia—Methotrexate—colon cancer	0.000192	0.00108	CcSEcCtD
Ursodeoxycholic acid—Malnutrition—Methotrexate—colon cancer	0.00019	0.00106	CcSEcCtD
Ursodeoxycholic acid—Nausea—Vincristine—colon cancer	0.000189	0.00106	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000189	0.00106	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Fluorouracil—colon cancer	0.000189	0.00106	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000188	0.00584	CbGpPWpGaD
Ursodeoxycholic acid—Insomnia—Capecitabine—colon cancer	0.000188	0.00106	CcSEcCtD
Ursodeoxycholic acid—Rash—Fluorouracil—colon cancer	0.000187	0.00105	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Fluorouracil—colon cancer	0.000187	0.00105	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Capecitabine—colon cancer	0.000187	0.00105	CcSEcCtD
Ursodeoxycholic acid—Headache—Fluorouracil—colon cancer	0.000186	0.00105	CcSEcCtD
Ursodeoxycholic acid—Dyspnoea—Capecitabine—colon cancer	0.000185	0.00104	CcSEcCtD
Ursodeoxycholic acid—Nausea—Irinotecan—colon cancer	0.000184	0.00104	CcSEcCtD
Ursodeoxycholic acid—Back pain—Methotrexate—colon cancer	0.000183	0.00103	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Capecitabine—colon cancer	0.000183	0.00103	CcSEcCtD
Ursodeoxycholic acid—Decreased appetite—Capecitabine—colon cancer	0.000181	0.00101	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Capecitabine—colon cancer	0.000179	0.00101	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Capecitabine—colon cancer	0.000179	0.00101	CcSEcCtD
Ursodeoxycholic acid—Pain—Capecitabine—colon cancer	0.000178	0.000998	CcSEcCtD
Ursodeoxycholic acid—Constipation—Capecitabine—colon cancer	0.000178	0.000998	CcSEcCtD
Ursodeoxycholic acid—Nausea—Fluorouracil—colon cancer	0.000177	0.000992	CcSEcCtD
Ursodeoxycholic acid—Ill-defined disorder—Methotrexate—colon cancer	0.000176	0.000988	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—HNF4A—colon cancer	0.000175	0.00545	CbGpPWpGaD
Ursodeoxycholic acid—Anaemia—Methotrexate—colon cancer	0.000175	0.000984	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Fluoropyrimidine Activity—TP53—colon cancer	0.000171	0.00532	CbGpPWpGaD
Ursodeoxycholic acid—Feeling abnormal—Capecitabine—colon cancer	0.000171	0.000962	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—ODC1—colon cancer	0.000171	0.00531	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—CHST5—colon cancer	0.000171	0.00531	CbGpPWpGaD
Ursodeoxycholic acid—Malaise—Methotrexate—colon cancer	0.000171	0.00096	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Methotrexate—colon cancer	0.00017	0.000957	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Capecitabine—colon cancer	0.00017	0.000955	CcSEcCtD
Ursodeoxycholic acid—Leukopenia—Methotrexate—colon cancer	0.00017	0.000953	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—CA7—colon cancer	0.000166	0.00517	CbGpPWpGaD
Ursodeoxycholic acid—Cough—Methotrexate—colon cancer	0.000165	0.000929	CcSEcCtD
Ursodeoxycholic acid—Urticaria—Capecitabine—colon cancer	0.000165	0.000927	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Capecitabine—colon cancer	0.000164	0.000923	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Capecitabine—colon cancer	0.000164	0.000923	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Methotrexate—colon cancer	0.000164	0.000923	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Methotrexate—colon cancer	0.000161	0.000907	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Methotrexate—colon cancer	0.000161	0.000907	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Methotrexate—colon cancer	0.000161	0.000907	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000161	0.00499	CbGpPWpGaD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00016	0.0009	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Methotrexate—colon cancer	0.000159	0.000896	CcSEcCtD
Ursodeoxycholic acid—Confusional state—Methotrexate—colon cancer	0.000156	0.000876	CcSEcCtD
Ursodeoxycholic acid—NR1H4—PPARA activates gene expression—EP300—colon cancer	0.000156	0.00484	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—CHST5—colon cancer	0.000155	0.00482	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—ODC1—colon cancer	0.000155	0.00482	CbGpPWpGaD
Ursodeoxycholic acid—Infection—Methotrexate—colon cancer	0.000154	0.000863	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Capecitabine—colon cancer	0.000153	0.00086	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000153	0.00474	CbGpPWpGaD
Ursodeoxycholic acid—Nervous system disorder—Methotrexate—colon cancer	0.000152	0.000852	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Methotrexate—colon cancer	0.000151	0.000851	CcSEcCtD
Ursodeoxycholic acid—Skin disorder—Methotrexate—colon cancer	0.00015	0.000844	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Transmembrane transport of small molecules—ABCB1—colon cancer	0.00015	0.00465	CbGpPWpGaD
Ursodeoxycholic acid—Hyperhidrosis—Methotrexate—colon cancer	0.00015	0.00084	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Capecitabine—colon cancer	0.000149	0.000838	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Methotrexate—colon cancer	0.000147	0.000828	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Capecitabine—colon cancer	0.000147	0.000826	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Methotrexate—colon cancer	0.000145	0.000812	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Capecitabine—colon cancer	0.000142	0.000799	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000141	0.000792	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Methotrexate—colon cancer	0.00014	0.000786	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Methotrexate—colon cancer	0.000139	0.00078	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—CA7—colon cancer	0.000139	0.00431	CbGpPWpGaD
Ursodeoxycholic acid—Dyspnoea—Methotrexate—colon cancer	0.000138	0.000775	CcSEcCtD
Ursodeoxycholic acid—Somnolence—Methotrexate—colon cancer	0.000138	0.000773	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Capecitabine—colon cancer	0.000137	0.000772	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Methotrexate—colon cancer	0.000136	0.000765	CcSEcCtD
Ursodeoxycholic acid—Decreased appetite—Methotrexate—colon cancer	0.000134	0.000755	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Methotrexate—colon cancer	0.000134	0.00075	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Methotrexate—colon cancer	0.000133	0.000749	CcSEcCtD
Ursodeoxycholic acid—Pain—Methotrexate—colon cancer	0.000132	0.000743	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Capecitabine—colon cancer	0.000132	0.000742	CcSEcCtD
Ursodeoxycholic acid—Rash—Capecitabine—colon cancer	0.000131	0.000736	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Capecitabine—colon cancer	0.000131	0.000735	CcSEcCtD
Ursodeoxycholic acid—Headache—Capecitabine—colon cancer	0.00013	0.000731	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Methotrexate—colon cancer	0.000127	0.000716	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Methotrexate—colon cancer	0.000126	0.000711	CcSEcCtD
Ursodeoxycholic acid—Nausea—Capecitabine—colon cancer	0.000123	0.000693	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000123	0.00382	CbGpPWpGaD
Ursodeoxycholic acid—Urticaria—Methotrexate—colon cancer	0.000123	0.00069	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Methotrexate—colon cancer	0.000122	0.000687	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Methotrexate—colon cancer	0.000122	0.000687	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Methotrexate—colon cancer	0.000114	0.00064	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Platelet degranulation—VEGFA—colon cancer	0.000112	0.00347	CbGpPWpGaD
Ursodeoxycholic acid—Asthenia—Methotrexate—colon cancer	0.000111	0.000624	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.00011	0.0034	CbGpPWpGaD
Ursodeoxycholic acid—Pruritus—Methotrexate—colon cancer	0.000109	0.000615	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	0.000106	0.0033	CbGpPWpGaD
Ursodeoxycholic acid—Diarrhoea—Methotrexate—colon cancer	0.000106	0.000595	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000105	0.00327	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet degranulation—TGFB1—colon cancer	0.000102	0.00318	CbGpPWpGaD
Ursodeoxycholic acid—Dizziness—Methotrexate—colon cancer	0.000102	0.000575	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—CHST5—colon cancer	0.000101	0.00313	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—ODC1—colon cancer	0.000101	0.00313	CbGpPWpGaD
Ursodeoxycholic acid—Vomiting—Methotrexate—colon cancer	9.84e-05	0.000553	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	9.76e-05	0.00303	CbGpPWpGaD
Ursodeoxycholic acid—Rash—Methotrexate—colon cancer	9.75e-05	0.000548	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Methotrexate—colon cancer	9.74e-05	0.000547	CcSEcCtD
Ursodeoxycholic acid—Headache—Methotrexate—colon cancer	9.69e-05	0.000544	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.67e-05	0.003	CbGpPWpGaD
Ursodeoxycholic acid—Nausea—Methotrexate—colon cancer	9.19e-05	0.000516	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ABCB1—colon cancer	8.75e-05	0.00272	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.62e-05	0.00268	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—HNF4A—colon cancer	8.44e-05	0.00262	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—ODC1—colon cancer	8.42e-05	0.00261	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—CHST5—colon cancer	8.42e-05	0.00261	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Ectoderm Differentiation—CTNNB1—colon cancer	8.2e-05	0.00255	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.04e-05	0.0025	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—CA7—colon cancer	7.9e-05	0.00245	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—ABCB1—colon cancer	7.87e-05	0.00244	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—TYMS—colon cancer	7.73e-05	0.0024	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—PPARG—colon cancer	7.61e-05	0.00237	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.17e-05	0.00223	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.06e-05	0.00219	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—ABCB1—colon cancer	7.01e-05	0.00218	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—TYMS—colon cancer	6.89e-05	0.00214	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Ectoderm Differentiation—MYC—colon cancer	6.64e-05	0.00206	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.4e-05	0.00199	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—NRF2 pathway—TGFB1—colon cancer	6.33e-05	0.00197	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.95e-05	0.00185	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.55e-05	0.00173	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—PPARG—colon cancer	5.47e-05	0.0017	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—NRF2 pathway—TGFB1—colon cancer	5.34e-05	0.00166	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.3e-05	0.00165	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	5.13e-05	0.00159	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	5.09e-05	0.00158	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.04e-05	0.00156	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	4.95e-05	0.00154	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—PPARG—colon cancer	4.88e-05	0.00152	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—CHST5—colon cancer	4.78e-05	0.00149	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—ODC1—colon cancer	4.78e-05	0.00149	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—ABCB1—colon cancer	4.75e-05	0.00147	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.62e-05	0.00143	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	4.55e-05	0.00141	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—ABCB1—colon cancer	4.52e-05	0.0014	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—TYMS—colon cancer	4.44e-05	0.00138	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—colon cancer	4.34e-05	0.00135	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	4.32e-05	0.00134	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—PTGS2—colon cancer	4.31e-05	0.00134	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.19e-05	0.0013	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.16e-05	0.00129	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—ABCB1—colon cancer	4.1e-05	0.00127	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—TYMS—colon cancer	4.02e-05	0.00125	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	3.87e-05	0.0012	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—PTGS2—colon cancer	3.84e-05	0.00119	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—PPARG—colon cancer	3.67e-05	0.00114	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—EP300—colon cancer	3.58e-05	0.00111	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.47e-05	0.00108	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.42e-05	0.00106	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.27e-05	0.00102	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—EP300—colon cancer	3.19e-05	0.000992	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	3.16e-05	0.000982	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—PPARG—colon cancer	3.14e-05	0.000977	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.1e-05	0.000962	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—PPARG—colon cancer	2.85e-05	0.000885	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.73e-05	0.000849	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.72e-05	0.000846	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—EP300—colon cancer	2.7e-05	0.000837	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—ABCB1—colon cancer	2.66e-05	0.000827	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—PIK3CA—colon cancer	2.65e-05	0.000823	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—SRC—colon cancer	2.62e-05	0.000814	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—TYMS—colon cancer	2.62e-05	0.000813	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—VEGFA—colon cancer	2.55e-05	0.000793	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—NRAS—colon cancer	2.52e-05	0.000783	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—PTGS2—colon cancer	2.47e-05	0.000768	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—PIK3CA—colon cancer	2.36e-05	0.000734	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—TGFB1—colon cancer	2.34e-05	0.000728	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.27e-05	0.000706	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—PTGS2—colon cancer	2.24e-05	0.000697	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—ABCB1—colon cancer	2.22e-05	0.000691	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—TYMS—colon cancer	2.18e-05	0.000678	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—KRAS—colon cancer	2.17e-05	0.000674	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—AKT1—colon cancer	2.16e-05	0.000672	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—MYC—colon cancer	2.09e-05	0.000649	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—EP300—colon cancer	2.06e-05	0.000639	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.01e-05	0.000626	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—PIK3CA—colon cancer	1.99e-05	0.000619	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—AKT1—colon cancer	1.93e-05	0.000599	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—TP53—colon cancer	1.93e-05	0.000599	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—EP300—colon cancer	1.87e-05	0.000579	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—PPARG—colon cancer	1.85e-05	0.000576	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—HRAS—colon cancer	1.84e-05	0.000573	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.68e-05	0.000522	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—AKT1—colon cancer	1.63e-05	0.000506	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—PPARG—colon cancer	1.55e-05	0.000481	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—PIK3CA—colon cancer	1.52e-05	0.000473	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—PTGS2—colon cancer	1.46e-05	0.000453	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—AKT1—colon cancer	1.45e-05	0.00045	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—PIK3CA—colon cancer	1.38e-05	0.000429	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—ABCB1—colon cancer	1.26e-05	0.000393	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—AKT1—colon cancer	1.24e-05	0.000386	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—TYMS—colon cancer	1.24e-05	0.000386	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—PTGS2—colon cancer	1.22e-05	0.000378	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—EP300—colon cancer	1.21e-05	0.000377	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—AKT1—colon cancer	1.13e-05	0.00035	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—EP300—colon cancer	1.01e-05	0.000314	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—PIK3CA—colon cancer	8.97e-06	0.000279	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—PPARG—colon cancer	8.8e-06	0.000273	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—PIK3CA—colon cancer	7.49e-06	0.000233	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—AKT1—colon cancer	7.33e-06	0.000228	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—PTGS2—colon cancer	6.92e-06	0.000215	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—AKT1—colon cancer	6.12e-06	0.00019	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—EP300—colon cancer	5.75e-06	0.000179	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—PIK3CA—colon cancer	4.26e-06	0.000132	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—AKT1—colon cancer	3.48e-06	0.000108	CbGpPWpGaD
